FLT3 and neoplasm: A high frequency of FLT3-ITD somatic mutations in dogs with neoplastic mast cells elevated the WBC count, along with an increase in neutrophil subpopulations, corresponding to human AML patients harboring FLT3-ITD mutations with high tumor burden and poor clinical outcomes.